Cargando…
Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines
Pseudomyxoma peritonei (PMP) is a rare tumor of appendiceal origin. Treatment is major cytoreductive surgery but morbidity is high. PMP is considered chemo-resistant; its molecular biology is understudied; and presently, there is no platform for pre-clinical drug testing. Here, we performed exon arr...
Autores principales: | Roberts, Darren L., O'Dwyer, Sarah T., Stern, Peter L., Renehan, Andrew G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484419/ https://www.ncbi.nlm.nih.gov/pubmed/25929336 |
Ejemplares similares
-
A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei
por: Bibi, R, et al.
Publicado: (2006) -
Pseudomyxoma Peritonei Secondary to a Primary Appendix Tumor: A Belly Full of Jelly
por: Sorungbe, Adebola O, et al.
Publicado: (2019) -
Pseudomyxoma Peritonei
por: Homeag, Maria, et al.
Publicado: (2009) -
Approach to pseudomyxoma peritonei
por: Rizvi, Syed Ali, et al.
Publicado: (2018) -
A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei
por: Farquharson, A L, et al.
Publicado: (2008)